Hypofrontality and cognitive impairment in schizophrenia: Dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function

Biological Psychiatry

Volumn 27, Issue 4, 1990, Pages 377-399

  Paulman, Ronald G ^a,b   Devous Sr , Michael D ^a   Gregory, Rodrick R ^a   Herman, John H ^a   Jennings, Linda ^a   Bonte, Frederick J ^a   Nasrallah, Henry A ^c   Raese, Joachim D ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COGNITION; FRONTAL LOBE; HUMAN; PARANOIA; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SCHIZOPHRENIA;

ADULT; CARBON DIOXIDE; COGNITION DISORDERS; FRONTAL LOBE; HUMAN; MALE; MIDDLE AGE; OBSERVER VARIATION; PSYCHOLOGICAL TESTS; REGIONAL BLOOD FLOW; SCHIZOPHRENIA; SCHIZOPHRENIA, PARANOID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0025017081     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(90)90549-H     Document Type: Article

References (89)

1. Breast lesion classification by computer and xeroradiograph
2. Positive vs. negative schizophrenia: A critical evaluation
3. Structural abnormalities in the frontal system in schizophrenia
4. Negative symptoms in schizophrenia: Definition and reliability
5. Negative v. positive schizophrenia
6. Ventricular enlargement in schizophrenia Definition and prevalence
7. Regional cerebral blood flow in schizophrenics
8. Pharmacology of mesocortical dopamine neurons
9. Psychiatric conditions associated with focal lesions of the central nervous system
10. Xenon 133 inhalation regional cerebral blood flow: Application to psychiatric research
11. A relationship between anatomical and physiological brain pathology in schizophrenia: Lateral cerebral ventricular size predicts cortical blood flow
12. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia
13. Symptomatic and neuropsychological components of defect states
14. Personality changes with frontal and temporal lobe lesions
15. Basal ganglia and limbic system pathology in schizophrenia: A Morphometric study
16. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey
17. Prolonged hypercarbia in the awake newborn piglet: Effect on brain blood flow and cardiac output
18. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders
19. Cerebral glucography with positron tomography use in normal subjects and inpatients with schizophrenia
20. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients
21. A method for calculating regional cerebral blood flow from emission computerized tomography of inert gas concentrations
22. Cerebral blood flow in schizophrenic adolescents
23. Increased frontal and reduced parietal glucose metabolism in acute untreated Schizophrenia
24. A coefficient of agreement for normal scales
25. The two-syndrome concept: Origins and current status
26. Clinical correlates of decreased antero-posterior metabolic gradients in Positron Emission Tomography (PET) of schizophrenic patients
27. Imaging brain function by single-photon emission computed tomography
28. Quantitative imaging of regional cerebral blood flow by dynamic single-photon tomography
29. Normal distribution of regional cerebral blood flow measured by dynamic single-photon emission tomography
30. 2
31. Regional brain glucose metabolism in chronic schizophrenia
32. Lateralized temporal limbic dysfunction and psychopathology
33. Neuropsychological dimensions in psychopathology
34. Abnormal distribution of cerebral activity in chronic schizophrenia
35. Structural brain deficits in schizophrenia: Identification by computer tomographic scan density measurements
36. Cross-validation of the ability of the Luria-Nebraska Neuropsychological Battery to differentiate chronic schizophrenics with and without ventricular enlargement
37. Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics: Measurement by the standardized Luria-Nebraska Neuropsychological Battery
38. The neuropsychology of schizophrenia
39. Neuropsychological performance and positive and negative symptoms in schizophrenia
40. 2 on cerebral blood volume, blood flow, and vascular mean transit time
41. Brain function in psychiatric disorders III: Regional cerebral blood flow in unmedicated schizophrenics
42. Regional brain function in schizophrenia I: A position emission tomography study
43. Brain function in psychiatric disorders I: Regional cerebral blood flow in medicated schizophrenics
44. Information processing aspects of neurotic anxiety and the schizophrenias
45. Blood flow and oxidative metabolism of the brain in patients with schizophrenia
46. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia
47. Uno multi: Subtyping the schizophrenic syndrome
48. Two methods for calculating regional cerabral blood flow from emission computed tomography of inert gas concentrations
49. First order correction for absorption and resolution compensation in radionuclide Fourier tomography
50. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression
51. Schizophrenia with good and poor outcome I: Early clinical features, response to neuroleptics and signs of organic dysfunction
52. The effects of chronicity and length of hospitalization on the standard version of Luria's neuropsychological battery in a schizophrenic population
53. Regional cerebral blood flow in schizophrenia
54. Multiple contributions to clinical presentation of flat affect in schizophrenia
55. ROC methodology in radiologic imaging
56. Behavioral effects of frontal-lobe lesions in man
57. Statistical modeling and diagnostic aids
58. The Brief Psychiatric Rating Scale
59. Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder
60. Deficits on subject-ordered tasks after frontal-and temporal-lobe lesions in man
61. Discrimination between schizophrenics and brain-damaged patients using the Luria-Nebraska Neuropsychological Battery
62. The utility of the Wisconsin Card Sorting Test in detecting and localizing frontal lobe lesions
63. Anatomical and physiological substrates of arousal—a view from the bridge
64. Treatment response and ventricular brain enlargement in young schizophrenic patients
65. Discrimination of chronic schizophrenia and brain damage with the Luria-Nebraska battery: A partially successful replication
66. Cerebral structural pathology in schizophrenia: Evidence for a selective prefrontal cortical defect
67. 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients
68. Dopaminergic A10 neurons are involved in cognitive functions
69. An error analysis of the double-integral method for calculating brain blood perfusion from inert gas clearance data
70. Negative symptoms: Conceptual and methodological problems
71. Neuropathology of schizophrenia
72. A single-photon dynamic computer-assisted tomograph (DCAT) for imaging brain function in multiple cross-sections
73. Interactive graphics method of regional quantification of tomographic brain blood flow images
74. Neuropsychological studies of the frontal lobes
75. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia
76. Implications of normal brain development for the pathogenesis of schizophrenia
77. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia
78. Computed tomography in schizophreniform disorder and other acute psychiatric disorders
79. Glucose metabolism in patients with schizophrenia: Emission computed tomography measurements with 11-C-glucose
80. Schizophrenia with good and poor outcome II: Cerebral ventricular size and its clinical significance
81. Low frontal glucose utilization in chronic schizophrenia: A replication study
82. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by Positron Emission Tomography
83. Theoretical, methodological, and statistical implications of the inhalation rCBF technique for the study of brain-behavior relationships